Citigroup’s Crescent Biopharma, Inc. Common Stock CBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-1,377
Closed -$413K 4821
2024
Q1
$413K Buy
1,377
+1,162
+540% +$349K ﹤0.01% 2957
2023
Q4
$50.8K Buy
+215
New +$50.8K ﹤0.01% 3765
2021
Q2
Sell
-31
Closed -$9K 5514
2021
Q1
$9K Sell
31
-44
-59% -$12.8K ﹤0.01% 5025
2020
Q4
$28K Buy
75
+23
+44% +$8.59K ﹤0.01% 4443
2020
Q3
$16K Sell
52
-28
-35% -$8.62K ﹤0.01% 4065
2020
Q2
$30K Sell
80
-44
-35% -$16.5K ﹤0.01% 4005
2020
Q1
$28K Buy
124
+12
+11% +$2.71K ﹤0.01% 4179
2019
Q4
$59K Sell
112
-12
-10% -$6.32K ﹤0.01% 3852
2019
Q3
$53K Sell
124
-340
-73% -$145K ﹤0.01% 3746
2019
Q2
$553K Buy
464
+347
+297% +$414K ﹤0.01% 2597
2019
Q1
$146K Sell
117
-1,031
-90% -$1.29M ﹤0.01% 3331
2018
Q4
$1.09M Buy
1,148
+358
+45% +$339K ﹤0.01% 1950
2018
Q3
$1.14M Buy
790
+196
+33% +$282K ﹤0.01% 1900
2018
Q2
$958K Sell
594
-70
-11% -$113K ﹤0.01% 1912
2018
Q1
$1.08M Buy
664
+653
+5,936% +$1.06M ﹤0.01% 1775
2017
Q4
$18K Buy
+11
New +$18K ﹤0.01% 4277
2017
Q3
Hold
0
4752
2017
Q2
Hold
0
4906
2017
Q1
Hold
0
4843
2016
Q4
Sell
-10
Closed -$7K 4891
2016
Q3
$7K Hold
10
﹤0.01% 4545
2016
Q2
$8K Buy
+10
New +$8K ﹤0.01% 4582
2015
Q4
Sell
-20
Closed -$11K 5485
2015
Q3
$11K Hold
20
﹤0.01% 4337
2015
Q2
$16K Sell
20
-15
-43% -$12K ﹤0.01% 4364
2015
Q1
$29K Buy
35
+34
+3,400% +$28.2K ﹤0.01% 4175
2014
Q4
$1K Sell
1
-1
-50% -$1K ﹤0.01% 5319
2014
Q3
$1K Buy
+2
New +$1K ﹤0.01% 5250
2014
Q2
Hold
0
5532
2014
Q1
Hold
0
5486